Consultant Thoracic Surgeon
02074... 02074594367 Reveal phone no. >
Mr Marco Scarci: Consultant Thoracic Surgeon in London
Mr Marco Scarci is a leading Consultant Thoracic Surgeon based in London, specialising in minimally invasive thoracic surgery, lung cancer treatment, chest wall reconstruction, and complex pleural disease management across several major private hospitals.
Education & Experience
Mr Marco Scarci is an accomplished Consultant Thoracic Surgeon with extensive experience in advanced chest and lung surgery. They have built a reputation for excellence through years of clinical practice and surgical innovation in both the NHS and private sectors.
They currently practise at Imperial College Healthcare NHS Trust and see private patients at several of London’s most respected hospitals, including The Bupa Cromwell Hospital, The London Clinic, The Platinum Centre at The Wellington, Elstree Waterfront Outpatients Centre, and Imperial Private Healthcare at The Hammersmith Hospital.
Mr Scarci is particularly recognised for introducing and developing single-incision VATS (Video-Assisted Thoracoscopic Surgery) techniques in the UK—an approach that enables patients to recover more comfortably with reduced post-operative pain and shorter hospital stays. Their expertise extends across the full spectrum of thoracic procedures, from lung cancer resections to complex chest wall reconstructions and management of pleural conditions.
Throughout their career, they have maintained a commitment to combining surgical precision with patient-centred care, ensuring that every treatment plan is tailored to the individual’s needs using the most current evidence-based methods.
Treatments
- Minimally invasive thoracic surgery (VATS / keyhole chest surgery)
- Lung cancer and mediastinal tumour surgery
- Chest wall deformities (pectus excavatum, pectus carinatum)
- Pleural disease (mesothelioma, pleural effusion)
- Hyperhidrosis and sympathectomy
- Rib fractures and slipping rib syndrome
- Cancer surgery – including lobectomy (lung)
- Mesothelioma treatments
Initial consultation fee: £300
Follow-up consultation fee: £225
Research Interests
Mr Scarci’s research has focused on improving surgical outcomes for thoracic patients, particularly in the areas of minimally invasive lung surgery and chest wall reconstruction. They have a strong interest in lung cancer surgery, including techniques such as wedge resection, segmentectomy, lobectomy, and pneumonectomy, as well as procedures for pleural disease and thymus gland tumours.
Further research areas include congenital and acquired chest wall deformities, thymomas, and the management of hyperhidrosis and erythrophobia. They continue to contribute to academic and clinical discussions around refining surgical methods to enhance safety, comfort, and recovery for patients.
Clinical Interests
Their clinical practice encompasses a broad range of thoracic conditions, including:
- Lung cancer and mediastinal tumours
- Chest wall deformities – pectus excavatum and pectus carinatum
- Rib fractures, slipping rib syndrome, and chest wall pain
- Pleural conditions such as mesothelioma and pleural effusion
- Collapsed lung (pneumothorax) and recurrent lung infections
- Lung nodules, cysts, and masses
- Thymomas and other thymus gland disorders
- Excessive sweating (hyperhidrosis) and facial blushing (erythrophobia)
Accolades & Awards
Mr Scarci is widely recognised for pioneering single-incision thoracic surgery techniques in the UK, a contribution that has significantly influenced modern thoracic surgical practice. Their dedication to advancing minimally invasive approaches has earned them respect among peers and patients alike.
Memberships & Associations
- European Society of Thoracic Surgeons (ESTS)
- Society for Cardiothoracic Surgery in Great Britain & Ireland (SCTS)
- Fellow of the American College of Chest Physicians (FCCP)
- Fellow of the American College of Surgeons (FACS)
Profile: Marco Scarci authored by Jacky Cann, an experienced healthcare writer. Last updated: 23/10/2025
Healthcare information reviewed on 30/03/2025 by LaingBuisson's Digital Operations Manager Ben Reed.
Next review scheduled for 30/03/2026